Cargando…
Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines
BACKGROUND: Potent and safe adjuvants are needed to improve the efficacy of parenteral and mucosal vaccines. Cytokines, chemokines and growth factors have all proven to be effective immunomodulatory adjuvants when administered with a variety of antigens. We have previously evaluated the efficacy of...
Autores principales: | Khan, Tila, Heffron, Connie L, High, Kevin P, Roberts, Paul C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036309/ https://www.ncbi.nlm.nih.gov/pubmed/24884849 http://dx.doi.org/10.1186/1743-422X-11-78 |
Ejemplares similares
-
Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis
por: Keino, Hiroshi, et al.
Publicado: (2008) -
Homeostatic Regulation of Salmonella-Induced Mucosal Inflammation and Injury by IL-23
por: Awoniyi, Muyiwa, et al.
Publicado: (2012) -
From genes polymorphisms to mucosal expression of cytokines: evaluating IL-23/IL-17 axis in adult patients with gastritis
por: Azadegan-Dehkordi, Fatemeh, et al.
Publicado: (2020) -
The role of IL‐23 and the use of IL‐23 inhibitors in psoriatic arthritis
por: Fragoulis, George E., et al.
Publicado: (2022) -
The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation
por: Chognard, Gaëlle, et al.
Publicado: (2014)